Rhythm Pharmaceuticals News

Rhythm Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shulman Joseph

May 13 16:26 ET

Rhythm Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

May 9 16:23 ET

Rhythm Pharmaceuticals | 10-Q: Quarterly report

May 7 16:46 ET

Rhythm Pharmaceuticals | 8-K: Rhythm Pharmaceuticals Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Update

May 7 07:14 ET

Rhythm Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Apr 30 19:37 ET

Rhythm Pharmaceuticals | DEF 14A: Definitive information statements

Apr 26 16:34 ET

Rhythm Pharmaceuticals | ARS: Annual Report to Security Holders

Apr 26 16:20 ET

Rhythm Pharmaceuticals | DEFA14A: Others

Apr 26 16:18 ET

Rhythm Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(8.3%),Joseph Edelman(8.3%), etc.

Apr 17 16:20 ET

Rhythm Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mazabraud Yann

Apr 16 20:16 ET

Rhythm Pharmaceuticals | 8-K: Current report

Apr 16 07:04 ET

Rhythm Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer German Christopher Paul

Apr 3 20:04 ET

Rhythm Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(5.4%),Perceptive Life Sciences Master Fund, Ltd.(5.4%), etc.

Apr 3 18:19 ET

Rhythm Pharmaceuticals | 8-K: Current report

Apr 1 17:29 ET

Rhythm Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shulman Joseph

Mar 22 16:59 ET

Rhythm Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Lee Jennifer Kayden

Mar 22 16:19 ET

Rhythm Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 21 16:27 ET

Rhythm Pharmaceuticals | SC 13D: Statement of acquisition of beneficial ownership by individuals-Perceptive Advisors LLC(5.4%),Perceptive Life Sciences Master Fund, Ltd.(5.4%), etc.

Mar 20 17:54 ET

Rhythm Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 20 16:44 ET

Rhythm Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Smith Hunter C

Mar 19 21:03 ET